ELIS SA (ELIS.PA)

FR0012435121 - Common Stock

19.17  -0.1 (-0.52%)

Fundamental Rating

4

Taking everything into account, ELIS scores 4 out of 10 in our fundamental rating. ELIS was compared to 44 industry peers in the Commercial Services & Supplies industry. While ELIS is still in line with the averages on profitability rating, there are concerns on its financial health. ELIS is valued correctly, but it does not seem to be growing.



6

1. Profitability

1.1 Basic Checks

In the past year ELIS was profitable.
In the past year ELIS had a positive cash flow from operations.
In the past 5 years ELIS has always been profitable.
Each year in the past 5 years ELIS had a positive operating cash flow.

1.2 Ratios

ELIS has a Return On Assets (2.64%) which is comparable to the rest of the industry.
The Return On Equity of ELIS (7.09%) is comparable to the rest of the industry.
The Return On Invested Capital of ELIS (4.98%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ELIS is below the industry average of 8.78%.
The 3 year average ROIC (3.94%) for ELIS is below the current ROIC(4.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.64%
ROE 7.09%
ROIC 4.98%
ROA(3y)2.21%
ROA(5y)1.68%
ROE(3y)5.91%
ROE(5y)4.52%
ROIC(3y)3.94%
ROIC(5y)3.44%

1.3 Margins

Looking at the Profit Margin, with a value of 5.45%, ELIS is in the better half of the industry, outperforming 75.61% of the companies in the same industry.
In the last couple of years the Profit Margin of ELIS has grown nicely.
ELIS's Operating Margin of 11.47% is amongst the best of the industry. ELIS outperforms 85.37% of its industry peers.
In the last couple of years the Operating Margin of ELIS has grown nicely.
With a Gross Margin value of 32.81%, ELIS is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ELIS has grown nicely.
Industry RankSector Rank
OM 11.47%
PM (TTM) 5.45%
GM 32.81%
OM growth 3Y22.26%
OM growth 5Y5.06%
PM growth 3Y298.56%
PM growth 5Y18.35%
GM growth 3Y3.37%
GM growth 5Y1.99%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELIS is still creating some value.
The number of shares outstanding for ELIS has been increased compared to 1 year ago.
The number of shares outstanding for ELIS has been increased compared to 5 years ago.
ELIS has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that ELIS is in the distress zone and has some risk of bankruptcy.
ELIS has a Altman-Z score of 1.24. This is in the lower half of the industry: ELIS underperforms 65.85% of its industry peers.
The Debt to FCF ratio of ELIS is 7.60, which is on the high side as it means it would take ELIS, 7.60 years of fcf income to pay off all of its debts.
ELIS has a better Debt to FCF ratio (7.60) than 60.98% of its industry peers.
ELIS has a Debt/Equity ratio of 0.99. This is a neutral value indicating ELIS is somewhat dependend on debt financing.
ELIS has a Debt to Equity ratio (0.99) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 7.6
Altman-Z 1.24
ROIC/WACC1.03
WACC4.83%

2.3 Liquidity

ELIS has a Current Ratio of 0.74. This is a bad value and indicates that ELIS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ELIS (0.74) is worse than 85.37% of its industry peers.
ELIS has a Quick Ratio of 0.74. This is a bad value and indicates that ELIS is not financially healthy enough and could expect problems in meeting its short term obligations.
ELIS's Quick ratio of 0.66 is on the low side compared to the rest of the industry. ELIS is outperformed by 85.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.66

3

3. Growth

3.1 Past

ELIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.13%.
Measured over the past years, ELIS shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.57% on average per year.
The Revenue has been growing slightly by 7.65% in the past year.
Measured over the past years, ELIS shows a small growth in Revenue. The Revenue has been growing by 6.58% on average per year.
EPS 1Y (TTM)-17.13%
EPS 3Y363.54%
EPS 5Y22.57%
EPS Q2Q%-13.4%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y15.37%
Revenue growth 5Y6.58%
Sales Q2Q%6.92%

3.2 Future

Based on estimates for the next years, ELIS will show a small growth in Earnings Per Share. The EPS will grow by 5.29% on average per year.
Based on estimates for the next years, ELIS will show a small growth in Revenue. The Revenue will grow by 4.92% on average per year.
EPS Next Y5.41%
EPS Next 2Y6.14%
EPS Next 3Y5.9%
EPS Next 5Y5.29%
Revenue Next Year6.62%
Revenue Next 2Y5.38%
Revenue Next 3Y4.88%
Revenue Next 5Y4.92%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.61, the valuation of ELIS can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as ELIS.
ELIS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 30.45.
A Price/Forward Earnings ratio of 9.57 indicates a reasonable valuation of ELIS.
Based on the Price/Forward Earnings ratio, ELIS is valued a bit cheaper than 75.61% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.99. ELIS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.61
Fwd PE 9.57

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELIS is valued a bit cheaper than 73.17% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ELIS is valued a bit cheaper than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.14
EV/EBITDA 5.56

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ELIS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.81
PEG (5Y)0.91
EPS Next 2Y6.14%
EPS Next 3Y5.9%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.31%, ELIS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.91, ELIS pays a bit more dividend than its industry peers.
ELIS's Dividend Yield is comparable with the S&P500 average which is at 2.26.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

The dividend of ELIS decreases each year by -2.69%.
Dividend Growth(5Y)-2.69%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

ELIS pays out 41.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.72%
EPS Next 2Y6.14%
EPS Next 3Y5.9%

ELIS SA

EPA:ELIS (9/18/2024, 7:00:00 PM)

19.17

-0.1 (-0.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.51B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.61
Fwd PE 9.57
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.81
PEG (5Y)0.91
Profitability
Industry RankSector Rank
ROA 2.64%
ROE 7.09%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.47%
PM (TTM) 5.45%
GM 32.81%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.74
Quick Ratio 0.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-17.13%
EPS 3Y363.54%
EPS 5Y
EPS Q2Q%
EPS Next Y5.41%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.65%
Revenue growth 3Y15.37%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y